Does modulation of P-glycoprotein have clinical relevance in pediatric acute myeloid leukemia?
Zwaan
Christian Michel
CM
den Boer
Monique L
ML
Kazemier
Karin M
KM
Hählen
Karel
K
Loonen
Anne H
AH
Reinhardt
Dirk
D
Creutzig
Ursula
U
Kaspers
Gertjan J L
GJ
Pieters
Rob
R
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000032:analysis / Q000096:biosynthesis*; D000328:Adult; D000367:Age Factors; D000911:Antibodies, Monoclonal / Q000737:chemistry; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D005260:Female; D005434:Flow Cytometry; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D016572:Cyclosporine